Drug-labels.com

Ran-Memantine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
10 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Ran-Memantine

ABOUT THIS MEDICATION

What the medication is used for:

RAN-MEMANTINE has been prescribed to you, by a doctor to relieve symptoms of Alzheimer’s disease.

What it does:

The brain contains N-methyl-D-aspartate (NMDA) receptors that are involved in transmitting nerve signals and may be important for learning and memory. Abnormal transmission of nerve signals through NMDA-receptors in the brain may affect memory and other mental functions and contribute to symptoms of Alzheimer’s disease. RAN-MEMANTINE belongs to a group of medicines called NMDA-receptor antagonists. The action of RAN-MEMANTINE on NMDA-receptors may help normalize the transmission of nerve signals, which may help slow the decline in some of the symptoms of Alzheimer disease.

When it should not be used:

  • You should not be taking RAN-MEMANTINE if you are pregnant, unless in the opinion of the doctor, the expected benefit to the patient markedly outweighs the possible hazards to the foetus.

  • You should not be taking RAN-MEMANTINE if you are breast-feeding.
  • Do not take RAN-MEMANTINE if you are allergic to it, or to any of the other ingredients listed in this leaflet (see ‘What the non-medicinal ingredients are’).
  • Stop taking RAN-MEMANTINE if you experience an allergic reaction or any severe side effect.

What the medicinal ingredient is:

Memantine hydrochloride

What the nonmedicinal ingredients are:

Colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide black, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, talc and titanium dioxide.

What dosage forms it comes in:

10 mg tablets.

WARNINGS AND PRECAUTIONS

BEFORE you use RAN-MEMANTINE talk to your doctor or pharmacist if:

  • You have/had a medical condition, including heart

    problems, uncontrolled hypertension (high blood pressure), history of seizures or kidney disease

  • You are taking any medications (prescription or non-prescription) or have taken any within the last 14 days.
  • You ever had an allergic reaction to any medication
  • You are pregnant or thinking of becoming pregnant, or if you are breast-feeding.
  • There are conditions which can change the speed at which the body would normally eliminate the drug over time and you should tell your doctor, as RAN-MEMANTINE dosage may have to be adjusted if:

    • You have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet)
    • You are suffering from renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction [kidney problems])
    • You have a urinary tract infection

Drugs that may interact with RAN-MEMANTINE include:

  • NMDA-receptor antagonists (e.g. amantadine)
  • Cimetidine
  • Ranitidine
  • Procainamide
  • Quinidine
  • Quinine
  • Hydrochlorothiazide (or any combination with hydrochlorothiazide)
  • Anticholinergics (generally used to treat movement disorders or intestinal cramps)
  • L-dopa and dopaminergic agonists (drugs such as bromocriptine, ropinirole, pramipexole)
  • Ketamine
  • Dextromethorphan (found in cough syrup labelled DM)
  • Anticoagulant (blood thinner) medications taken by mouth

INTERACTIONS WITH THIS MEDICATION

PROPER USE OF THIS MEDICATION

Usual dose:

  • It is important that you take RAN-MEMANTINE exactly as your doctor has instructed.
  • Usually your doctor will prescribe 20 mg per day, which you will take as two separate doses of 10 mg. In order to reduce the risk of side effects this dose will be achieved gradually by the following daily treatment scheme, starting at a dose of 5 mg per day:
10 mg Tablets
AMPM
Week 1½ tabletNone
Week 2½ tablet½ tablet
Week 31 tablet½ tablet
Week 4 and beyond1 tablet1 tablet
  • Never change the dose of RAN-MEMANTINE unless your doctor tells you to.
  • Swallow the tablets whole with some water. Do not chew tablets. RAN-MEMANTINE can be taken with or without food.

  • Continue to take RAN-MEMANTINE as long as directed by your doctor and you do not experience any unacceptable side effects. Your doctor should assess your treatment on a regular basis.

Overdose:

If you have accidentally taken too much RAN-MEMANTINE contact your regional Poison Control Centre, hospital emergency department or your doctor immediately, even if you do not feel sick. You may require medical attention. If you go to the doctor or the hospital, take the RAN-MEMANTINE container with you.

Missed Dose:

  • If you miss a dose, do not worry. Do not take the missed tablet(s) – just take the next dose when it is due.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, RAN-MEMANTINE can cause side effects, although not everybody gets them. In general, these are mild to moderate. If any of the side effects become severe or if they are troublesome or persistent, talk to your doctor.

Common side effects (affects 1 to 10 users in 100) may include:

  • headache
  • sleepiness
  • constipation

    • tiredness
    • confusion
    • hallucinations (strange visions or sounds)
    • vomiting
    • loss of appetite
    • dizziness
    • sleep disturbance
    • anxiety
    • high blood pressure
    • change in frequency of urination

Uncommon side effects (affects 1 to 10 users in 1000) may include:

  • fungal infections
  • changes in vision
  • skin allergies

Your doctor will tell you whether your illness allows you to drive or operate machinery. Also, as this product may cause sleepiness or dizziness, do not drive or operate machinery under these conditions.

Alzheimer's disease has been associated with depression, thoughts of suicide and suicide. These events have been reported in patients treated with RAN-MEMANTINE.

If you have previously experienced epileptic seizures, there is a possibility that RAN-MEMANTINE may increase the chances of one occurring.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency treatment
Only if severeIn all cases
UncommonFungal infection√
Abnormal gait [Abnormal way of walking]√
Heart failure [persistent chest pain, rapid heart rate, severe shortness of breath, swelling of legs or ankles, increased tiredness, lack of appetite, confusion]√

Venous blood

clotting [pain,

swelling,

changes in skin

color, increased

warmth in one

leg]

√

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effectTalk with your doctor or pharmacist

Stop taking drug and seek

immediate emergency treatment

Only if severeIn all cases
Very rareSeizures [loss of consciousness with uncontrollable shaking]√
Hepatitis/hepatic failure [yellow skin and eyes, nausea, loss of appetite, dark-coloured urine]√
Inflammation of the pancreas [severe upper stomach pain, often with nausea and vomiting]√
psychotic reactions√

Serious skin

reactions [rash,

red skin,

blistering of the

lips, eyes or

mouth, skin

peeling]

√

For example:

Stevens-Johnson Syndrome: Severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals

Acute Generalized Exanthematous Pustulosis: Red rash covered with small pus-filled bumps that can spread over the body, sometimes with a fever

Erythema Multiforme: Rash that may blister, with spots that look like small targets

√

This is not a complete list of side effects. For any unexpected effects while taking RAN-MEMANTINE, contact your doctor or pharmacist.

If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

HOW TO STORE IT

  • As with all medicines, keep RAN-MEMANTINE out of the reach of children.
  • Stored at room temperature (15° C to 30° C). Protect from moisture.
  • If your doctor tells you to stop taking your medicine you should return any leftover tablets to the pharmacist, unless the doctor tells you to keep them at home.

    REMEMBER: This medicine is for YOU or for someone in your care. Only a doctor can prescribe it, so never offer it to any other person, even if their symptoms seem to be the same as yours or as for the person in your care.

Reporting Side Effects

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect (http://hc-sc.gc.ca/dhp-mps/medeff/index-eng.php);
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program

      Health Canada, Postal Locator 0701E

      Ottawa, ON

      K1A 0K9

Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect (http://hc-sc.gc.ca/dhp-mps/medeff/index-eng.php).

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Ranbaxy Pharmaceuticals Canada Inc., at:

1-866-840-1340.

RANBAXY

Ranbaxy Pharmaceuticals Canada Inc.,

2680 Matheson Blvd. E., Suite 200

Mississauga, Ontario

L4W 0A5

Last revised: July 24, 2015

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02421364

Revision date stated in the text: July 24, 2015

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ran-Memantine

Rx or OTC
Prescription (Rx)?
DIN 02421364
Schedule(s) PRESCRIPTION
Active ingredient(s) Memantine hydrochloride 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DX Other anti-dementia drugs
          1. N06DX01 Memantine
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Cancelled Post Market
Current status date July 10, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.